相关实验视频

Updated: May 30, 2025

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
06:17

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

Published on: May 22, 2018

11.8K

通过胆固醇末端修饰的PEG囊泡和小来抑制Aβ聚合

Shota Watanabe1, Motoki Ueda1, Shoichiro Asayama1

  • 1Department of Applied Chemistry, Tokyo Metropolitan University, Tokyo 192-0397, Japan.

Pharmaceutics
|January 25, 2025
PubMed
概括

胆固醇-聚乙烯甘醇 (Chol-PEG) 组件在阿尔茨海默氏病 (AD) 治疗方面表现有前途. 霍尔-PEG500囊泡有效抑制粉样β (Aβ) 聚合,同时作为药物输送载体和治疗剂.

关键词:
阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.一个Aβ聚合的Aβ聚合.胆固醇末端修饰的PEG (Chol-PEG) 是一种胆固醇末端修饰的PEG.药物交付运营商运营商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商运输商米塞尔 (Micelle) 是一个小女孩.囊泡 囊泡是一种囊泡.

更多相关视频

A Tailored HPLC Purification Protocol That Yields High-purity Amyloid Beta 42 and Amyloid Beta 40 Peptides, Capable of Oligomer Formation06:34

A Tailored HPLC Purification Protocol That Yields High-purity Amyloid Beta 42 and Amyloid Beta 40 Peptides, Capable of Oligomer Formation

Published on: March 27, 2017

11.8K
Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices04:41

Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices

Published on: July 14, 2010

23.1K

相关概念视频

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
9.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
160